Immunocore Holdings PLC (NAS:IMCR)
$ 46.05 -1.93 (-4.02%) Market Cap: 2.30 Bil Enterprise Value: 1.85 Bil PE Ratio: 0 PB Ratio: 5.07 GF Score: 73/100

Immunocore Holdings PLC at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 05:00PM GMT
Release Date Price: $56.91 (+4.35%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. I'm Jess Fye, I'm a biotech analyst at JPMorgan, and we're delighted to be continuing the conference this morning with Immunocore. As I'm sure you all know, we've got a different format this year, so you don't have to shuffle over to another room for Q&A. We're going to have Q&A in the same room when the presentation ends.

If you want to ask a question, you can raise your hand, somebody will bring you a microphone or you can submit questions electronically, and I can read them off the iPad up here.

So with that out of the way, let me turn it over to Immunocore's CEO, Bahija Jallal for the presentation.

Bahija Jallal
Immunocore Holdings plc - CEO & Director

Great. Thank you, and good morning. Preparing for this talk, I was trying to see how to describe the journey in Immunocore and what kept coming to my mind is the Moroccan team in the World Cup. I'm Moroccan, obviously. And that's basically they've done what they've done is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot